pubmed.ncbi.nlm.nih.gov

14-3-3 proteins and spinocerebellar ataxia type 1: from molecular interaction to human neuropathology - PubMed

Review

14-3-3 proteins and spinocerebellar ataxia type 1: from molecular interaction to human neuropathology

Takahiko Umahara et al. Cerebellum. 2010 Jun.

Abstract

This mini-review focuses on the possible relevance of 14-3-3 proteins in spinocerebellar ataxia type 1 (SCA1). 14-3-3 proteins are mainly localized in the synapses and neuronal cytoplasm, and seven isoforms have been identified in mammals. This family of proteins was initially identified as adaptor proteins which bind to phosphoserine-containing motifs. Binding motifs and potential functions of 14-3-3 proteins are now recognized to have a wide range of functional relevance. SCA1 is an autosomal-dominant neurodegenerative disorder and is linked to polyglutamine expansion (ataxin-1 protein). The Zoghbi and Orr group showed direct interaction of 14-3-3 proteins with ataxin-1 where nuclear recruitment of the ataxin-1 protein is dependent on its phosphorylation. This targeted binding of 14-3-3 protein to phosphorylated ataxin-1 to stabilize ataxin-1 in cellular models was corroborated by our double-labeling study for expanded polyglutamine and 14-3-3 proteins which demonstrated colocalization of these two epitopes in the neuronal nuclei in human autopsied brains with SCA1. Ataxin-1/14-3-3 protein interaction is a new potential target for therapeutic intervention in the treatment of SCA1.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Cell. 1996 Nov 15;87(4):619-28 - PubMed
    1. Science. 2003 Jul 4;301(5629):59-60 - PubMed
    1. J Biol Chem. 2007 Feb 16;282(7):4748-4756 - PubMed
    1. Neurosci Lett. 2008 Jan 24;431(1):45-50 - PubMed
    1. EMBO J. 2006 Jan 11;25(1):211-21 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources